In addition to its TK activity, the SH2 domain of BCR-ABL1 is also required for induction of CML-like disease in mice, but, interestingly, SH2 is not required for lymphoid leukemogenesis [78]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.